FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064563 [Registered on: 20/03/2024] Trial Registered Prospectively
Last Modified On: 18/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Ayurvedic management of Kshinshukra with Gokshuradi Vati and Ashwagandhadi Taila Uttarabasti. 
Scientific Title of Study   Efficacy of Gokshuradi Vati orally with and without administration of Ashwagandhadi tail Uttarbasti in the mangement of Kshinashukra (Oligospermia)-a open labelled randamized clinical camparative clinical trial 
Trial Acronym  nill 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Digvijay Tanaji Patil 
Designation  M.D. Scholer 
Affiliation  Institute of Teaching and Research in Ayurveda Jamnagar 
Address  Department of Kayachikitsa 4th floor academic building ITRA Jamnagar

Jamnagar
GUJARAT
361008
India 
Phone  8788582935  
Fax    
Email  digvijaypatil31770@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Charmi S Mehta 
Designation  Lecture 
Affiliation  Institute of Teaching and Research in Ayurveda Jamnagar 
Address  Department of Kayachikitsa 4th floor academic building ITRA Jamnagar

Jamnagar
GUJARAT
361008
India 
Phone  9428862264  
Fax    
Email  csmehta@itra.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Digvijay Patil 
Designation  M.D. Scholer 
Affiliation  Institute of Teaching and Research in Ayurveda Jamnagar 
Address  Department of Kayachikitsa 4th floor academic building ITRA Jamnagar

Jamnagar
GUJARAT
361008
India 
Phone  8788582935  
Fax    
Email  digvijaypatil31770@gmail.com  
 
Source of Monetary or Material Support  
Institute of Teaching and Research in Ayurveda 
 
Primary Sponsor  
Name  Institute of Teaching and Research in Ayurveda 
Address  Institute of Teaching and Research in Ayurveda, Opp City B division Police station, Gurudwara road, Jamnagar, 361008, Gujarat, India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
nill  nill 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Digvijay Tanaji Patil  PG hospital OPD NO.13 INSTITUTE OF TEACHING AND RESEARCH IN AYURVEDA JAMNAGAR  Department of Kayachikitsa 4th floor academic building ITRA Jamnagar, Opp City B division Police station, Gurudwara road, Jamnagar, 361008, Gujarat, India
Jamnagar
GUJARAT 
8788582935

digvijaypatil31770@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Institute of Teaching and Research of Ayurveda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N461||Oligospermia. Ayurveda Condition: Kshinshukra,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Gokshuradi Vati, Reference: Asthanga Hridya, Uttara Tantra, Rasayana Adhyaya, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: -), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Ashwagandhadi Taila , Reference: Chakradatta Vatavyadhi Adhyaya, Route: Urethral, Dosage Form: Taila, Dose: 20(ml), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 14 Days, anupAna/sahapAna: No, Additional Information:
3Comparator ArmDrugClassical(1) Medicine Name: Gokshuradi Vati, Reference: Asthanga Hridya, Uttara Tantra, Rasayana Adhyaya, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: -Godugdha), Additional Information: -
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  40.00 Year(s)
Gender  Male 
Details  1 Male patients with age between 21 to 40 years
2 Patients having Sperm count less than 15 million per ml According to WHO 2021 and or Low sperm motility less than 50 percent SLP Sperm like particles
3 Patient with or without clinical presentation of Kshinashukra Daurbalya, Mukhashosha
 
 
ExclusionCriteria 
Details  1 Patients with sperm count more than 15 million per ml
2 Patients with age below 21 and above 40 years
3 Patients of aspermia and azoospermia
4 Patients suffering from Varicocele, accessory sex gland infection, STD, Systemic diseases like chronic renal failure CRF, Uncontrolled Hypertension BP more than150per90 mmHg, Diabetes mellitus RBS more than140 mg per dl
5 Genetic disorders like Klinfelter syndrome.
6 Patients taking treatment for major psychiatric illness
7 History of previous medication and trauma leading to oligospermia
8 Patients having Hematuria Blood in the urine, Chronic Cystitis, UTI, Kidney Stone, Bladder Stones
9 Known case of Cardiac Diseases History of Myocardial infraction, Ischemic heart disease
10 Patient suffering from Urethral Stricture, Phimosis, Meatal Stenosis, Hypospadiasis, Epispadiasis.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To increase sperm count and sperm motility of patient of Kshinashukra.  Group A- 16 weeks
Group B- 16 weeks
 
 
Secondary Outcome  
Outcome  TimePoints 
To treat infertility due to male factor and have healthy progeny.
2 To improve the quality of life of infertile couple.
 
02 month 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "30"
Final Enrollment numbers achieved (India)="30" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/05/2024 
Date of Study Completion (India) 27/10/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The trial is randomized clinical trial to evaluate the role of  Gokshuradi vati orally with and without administration of Ashwagandhadi Taila Uttarabasti in the management of kshinshukra(Oligospermia). Total 30 patient will be enrolled in the study. Selected patient will be divided into 2 groups on the basis of computer-generated randomization. In this study Gokshuradi vati 4 tab. BD before meal each of 500mg will be given orally with anupan of godugdha  for 8 weeks and Ashwagandhadi taila uttarbasti 20ml early morning for 14 days.In another group Gokshuradi vati 4tab.BD before meal orally with anupana of godugdha each of 500mg.for 8 weeks. follow-ups will be carried out at 15 days interval for 2month after treatment.  
Close